A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
- PMID: 20646946
- DOI: 10.1016/j.ijid.2010.02.2254
A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
Abstract
Background: Risk factors and outcome in patients who acquire nosocomial infections due to carbapenem-resistant Acinetobacter baumannii (CRAB) are rarely investigated.
Methods: A multicenter retrospective study was conducted to analyze the clinical and microbiological data of patients with nosocomial infections due to A. baumannii in 10 hospitals around Taiwan from May 2004 to December 2006. Comparisons were made between patients with infections due to CRAB and patients with infections due to carbapenem-susceptible A. baumannii (CSAB).
Results: One hundred and twenty-one patients carrying CRAB (infections, n=91) and 127 patients carrying CSAB (infections, n=97) were recruited for analysis. Compared with patients with CSAB infections, patients with CRAB infections had a longer duration of hospital stay before A. baumannii was isolated (median 48 vs. 21 days, p<0.001) and were more likely to have had exposure to a carbapenem (adjusted odds ratio (AOR) 2.57, 95% confidence interval (95% CI) 1.43-5.35; p=0.02) and an intensive care unit (ICU) stay (AOR 3.42, 95% CI 1.76-5.26; p=0.008). Risk factors associated with CRAB bacteremia included duration of hospital stay before onset of bacteremia (AOR 1.009 per 1-day longer, 95% CI 1.03-1.24; p=0.049), prior colonization with A. baumannii (AOR 3.27, 95% CI 1.99-5.93; p=0.002), and hospitalization in the ICU (AOR 6.12, 95% CI 1.58-13.68; p=0.009). Patients with CRAB bacteremia had a higher mortality rate than patients with CSAB bacteremia (46.0% vs. 28.3%, p=0.04). Multivariate analysis showed that carbapenem resistance (AOR 5.31, 95% CI 1.88-13.25; p=0.002), central venous catheterization (AOR 3.27, 95% CI 1.55-10.56; p=0.009), and ICU stay (AOR 2.56, 95% CI 1.15-8.85; p=0.04) were independent variables associated with mortality in patients with A. baumannii bacteremia.
Conclusions: Patients with CRAB infections have a higher mortality rate than those with CSAB infections. Longer hospital stay, colonization with A. baumannii, and admission to the ICU were associated with the development of CRAB bacteremia.
Copyright © 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.Int J Infect Dis. 2008 Jan;12(1):16-21. doi: 10.1016/j.ijid.2007.03.005. Epub 2007 May 21. Int J Infect Dis. 2008. PMID: 17513154
-
Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital.J Med Assoc Thai. 2009 Dec;92 Suppl 7:S173-80. J Med Assoc Thai. 2009. PMID: 20232570
-
Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.Southeast Asian J Trop Med Public Health. 2011 May;42(3):693-703. Southeast Asian J Trop Med Public Health. 2011. PMID: 21706949
-
[Multidrug resistant Acinetobacter baumanii:clinical update and new highlights].Rev Esp Quimioter. 2010 Mar;23(1):12-9. Rev Esp Quimioter. 2010. PMID: 20232019 Review. Spanish.
-
[Multidrug resistant Acinetobacter baumannii].Klin Mikrobiol Infekc Lek. 2008 Oct;14(5):162-7. Klin Mikrobiol Infekc Lek. 2008. PMID: 19051163 Review. Czech.
Cited by
-
Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children.Front Public Health. 2023 Nov 30;11:1282413. doi: 10.3389/fpubh.2023.1282413. eCollection 2023. Front Public Health. 2023. PMID: 38098829 Free PMC article.
-
Does Emerging Carbapenem Resistance in Acinetobacter baumannii Increase the Case Fatality Rate? Systematic Review and Meta-Analysis.Infect Dis Rep. 2023 Sep 27;15(5):564-575. doi: 10.3390/idr15050055. Infect Dis Rep. 2023. PMID: 37888136 Free PMC article. Review.
-
Moving toward Extensively Drug-Resistant: Four-Year Antimicrobial Resistance Trends of Acinetobacter baumannii from the Largest Department of Internal Medicine in Slovakia.Antibiotics (Basel). 2023 Jul 18;12(7):1200. doi: 10.3390/antibiotics12071200. Antibiotics (Basel). 2023. PMID: 37508296 Free PMC article.
-
Assessment of Effective Antimicrobial Regimens and Mortality-Related Risk Factors for Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.Infect Drug Resist. 2023 May 1;16:2589-2600. doi: 10.2147/IDR.S408927. eCollection 2023. Infect Drug Resist. 2023. PMID: 37152405 Free PMC article.
-
Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: A systematic review.J Infect Public Health. 2023 Mar;16(3):320-331. doi: 10.1016/j.jiph.2022.12.022. Epub 2022 Dec 31. J Infect Public Health. 2023. PMID: 36657243 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
